Cargando…
Development and consensus process for a clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathy
BACKGROUND: Cancer patients treated with neurotoxic chemotherapy are at risk of developing neurological symptoms that can impact functional capacity and quality of life. However, there are no standardised pathways to assess and manage chemotherapy-induced peripheral neurotoxicity (CIPN). This study...
Autores principales: | Mizrahi, David, Goldstein, David, Kiernan, Matthew C., Robinson, Louisa, Pitiyarachchi, Omali, McCullough, Susan, Mendoza-Jones, Phil, Grimison, Peter, Boyle, Frances, Park, Susanna B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135801/ https://www.ncbi.nlm.nih.gov/pubmed/35394563 http://dx.doi.org/10.1007/s00520-022-07024-3 |
Ejemplares similares
-
Association of electrochemical skin conductance with neuropathy in chemotherapy-treated patients
por: Mahfouz, Fawaz Mayez, et al.
Publicado: (2022) -
Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy
por: Mizrahi, David, et al.
Publicado: (2021) -
Relapsed/Refractory ETP-ALL Successfully Treated With Venetoclax and Nelarabine as a Bridge to Allogeneic Stem Cell Transplant
por: McEwan, Ashley, et al.
Publicado: (2020) -
Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use
por: Li, Tiffany, et al.
Publicado: (2022) -
Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy
por: Makker, Preet G. S., et al.
Publicado: (2017)